What is the current Inventiva market capitalization?
The current market capitalization of Inventiva is 148.75 M EUR.
Inventiva Market capitalization 2024
Inventiva Market capitalization
148.75 M EUR
Inventiva Dividend yield
Ticker
IVA.PA
ISIN
FR0013233012
WKN
A2DLV9
In 2024, Inventiva's market cap stood at 148.75 M EUR, a -4.07% increase from the 155.06 M EUR market cap in the previous year.
The Inventiva Market capitalization history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) | NET INCOME (undefined EUR) |
|---|---|---|---|
| 2029e | 426.09 | 4,18 | 6.91 |
| 2028e | 247.22 | 7,21 | -11.16 |
| 2027e | 68.59 | 25,98 | -49.4 |
| 2026e | 28.34 | 62,87 | -84.16 |
| 2025e | 11.82 | 150,68 | -100.62 |
| 2024e | 3.16 | 563,77 | -120.47 |
| 2023 | 17.48 | 101,93 | -110.43 |
| 2022 | 12.18 | 146,28 | -54.27 |
| 2021 | 4.19 | 178,35 | -49.64 |
| 2020 | 0.37 | 1186,56 | -33.62 |
| 2019 | 7 | 254,57 | -30.22 |
| 2018 | 3.2 | 557,24 | -33.62 |
| 2017 | 4.8 | 371,38 | -19.08 |
| 2016 | 9.45 | 188,61 | -7.05 |
| 2015 | 4.88 | 365,44 | -8.82 |
| 2014 | 3.28 | 542,64 | -7.49 |
| 2013 | 3.07 | 580,29 | -7.14 |
Inventiva Aktienanalyse
What does Inventiva do?
Inventiva SA is a biopharmaceutical company based in France that specializes in the development of novel therapies for various diseases. The company was founded in 2002 by Pierre Broqua and Frédéric Cren to develop innovative drugs based on research on the human genome. Inventiva's business model is to develop a pipeline of drug candidates and either sell them or bring them into partnerships with other companies. The company has built a broad portfolio of patents and license agreements that allow it to develop a variety of products. Inventiva's research and development focuses on three key areas: fibrosis, oncology, and autoimmune diseases. In these areas, the company has several product candidates in various stages of clinical development. Inventiva's products include Lanifibranor, a drug for the treatment of fatty liver disease, which is currently in Phase III trials. Additionally, the company has several compounds in its oncology pipeline, including IVA337, IVA336, and IVA339, all of which have shown promising results in preclinical studies. In the field of autoimmune diseases, Inventiva is working on a compound called ABBV-157, which is being developed in collaboration with Abbvie. This compound is intended to help reduce inflammation in patients with rheumatoid arthritis and psoriasis. Overall, Inventiva has made significant progress in recent years and has achieved important milestones in the development of its products. The company has also entered into several partnerships with major pharmaceutical and biotech companies to bring its products to market. In 2020, Inventiva took the next important step in its growth strategy by announcing a merger with American company AbbVie. The acquisition is expected to accelerate the development and commercialization of Inventiva's products and provide the company with a strong partner in the international market. However, Inventiva has not limited itself to drug development. The company has also developed a range of services to support other companies in the development of new drugs. These include laboratory services, protein purification and analysis, cell culture, and more, offered through their own contract research organization (CRO) unit. In summary, Inventiva is an emerging company with a strong portfolio of products and services. The company has done excellent work in developing new medical technologies in recent years and is likely to have even more success in the future with the acquisition by AbbVie. Inventiva ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Inventiva's Market Capitalization
Inventiva's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Inventiva's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Inventiva's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Inventiva’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Inventiva Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Inventiva.
How has the market capitalization of Inventiva developed in recent years?
The market capitalization of Inventiva has increased/decreased by -4.07% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Inventiva?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Inventiva?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Inventiva have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Inventiva pay?
Over the past 12 months, Inventiva paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inventiva is expected to pay a dividend of 0 EUR.
What is the dividend yield of Inventiva?
The current dividend yield of Inventiva is .
When does Inventiva pay dividends?
Inventiva pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Inventiva?
Inventiva paid dividends every year for the past 0 years.
What is the dividend of Inventiva?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Inventiva located?
Inventiva is assigned to the 'Health' sector.
Wann musste ich die Aktien von Inventiva kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Inventiva from 5/23/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/23/2024.
When did Inventiva pay the last dividend?
The last dividend was paid out on 5/23/2024.
What was the dividend of Inventiva in the year 2023?
In the year 2023, Inventiva distributed 0 EUR as dividends.
In which currency does Inventiva pay out the dividend?
The dividends of Inventiva are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Inventiva
Our stock analysis for Inventiva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inventiva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
